SCHEMBL25329435

SCHEMBL25329435

CC(C)(C)OC(=O)N1CCOC2(CCNCC2)CC1

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
RECQL P46063 1/20 0.44
MGLL Q99685 1/20 0.38
HPGD P15428 1/20 0.37
EPHX2 P34913 1/20 0.36
GPR119 Q8TDV5 3/20 0.36
NAMPT P43490 1/20 0.35
EPHX1 P07099 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
MAPK1 P28482 1/20 0.35
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2142321 0.94 USP2 (0.49) USP2SMN1; SMN2RECQLMGLLHPGD
SCHEMBL993522 0.89 USP2 (0.49) USP2SMN1; SMN2RECQLMGLLHPGD
SCHEMBL18053621 0.87 USP2 (0.59) USP2SMN1; SMN2RECQLMGLLHPGD
SCHEMBL13116090 0.84 USP2 (0.47) USP2SMN1; SMN2RECQLHPGDEPHX2
SCHEMBL996189 0.83 USP2 (0.49) USP2SMN1; SMN2RECQLMGLLHPGD
Hydrochloric Acid SCHEMBL31401199 0.83 USP2 (0.46) USP2SMN1; SMN2RECQLEPHX2NAMPT
SCHEMBL4278413 0.82 USP2 (0.54) USP2SMN1; SMN2RECQLMGLLHPGD
SCHEMBL23611994 0.82 USP2 (0.40) USP2SMN1; SMN2GPR119KDM4EMAPT
Hydrochloric Acid SCHEMBL1247006 0.82 USP2 (0.48) USP2SMN1; SMN2RECQLMGLLHPGD
SCHEMBL24803194 0.82 USP2 (0.54) USP2SMN1; SMN2RECQLMGLLHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4466260-A1 COMPOUNDS AND THEIR USE IN TREATING CANCER Astrazeneca AB (SE) 2024-11-27 EP disclosed
CN-118574821-A Compounds and their use in the treatment of cancer 阿斯利康(瑞典)有限公司 2024-08-30 CN disclosed
WO-2023139199-A1 COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2023-07-27 WO disclosed